{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T03:27:52Z","timestamp":1789529272688,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2007,7,4]],"date-time":"2007-07-04T00:00:00Z","timestamp":1183507200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1038\/sj.ejhg.5201885","type":"journal-article","created":{"date-parts":[[2007,7,4]],"date-time":"2007-07-04T09:33:40Z","timestamp":1183541620000},"page":"1054-1062","source":"Crossref","is-referenced-by-count":37,"title":["A sensitive assay for measuring SMN mRNA levels in peripheral blood and in muscle samples of patients affected with spinal muscular atrophy"],"prefix":"10.1038","volume":"15","author":[{"given":"Myriam","family":"Vezain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Saugier-Veber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Melki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annick","family":"Toutain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Bieth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Husson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Pedespan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Viollet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"P\u00e9nisson-Besnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Fehrenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Bou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Fr\u00e9bourg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Tosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,7,4]]},"reference":[{"key":"BF5201885_CR1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre S, B\u00fcrglen L, Reboullet S et al: Identification and characterization of a spinal muscular atrophy-determining gene. Cell 1995; 80: 155\u2013165.","journal-title":"Cell"},{"key":"BF5201885_CR2","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/ng854","volume":"30","author":"L Cartegni","year":"2002","unstructured":"Cartegni L, Krainer AR : Disruption of an SF2\/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat Genet 2002; 30: 377\u2013384.","journal-title":"Nat Genet"},{"key":"BF5201885_CR3","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/ng1207","volume":"34","author":"T Kashima","year":"2003","unstructured":"Kashima T, Manley JL : A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy. Nat Genet 2003; 34: 460\u2013463.","journal-title":"Nat Genet"},{"key":"BF5201885_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1086\/498853","volume":"78","author":"L Cartegni","year":"2006","unstructured":"Cartegni L, Hastings ML, Calarco JA, de Stanchina E, Krainer AR : Determinants of exon 7 splicing in the spinal muscular atrophy genes, SMN1 and SMN2. Am J Hum Genet 2006; 78: 63\u201377.","journal-title":"Am J Hum Genet"},{"key":"BF5201885_CR5","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/S0960-8966(99)00016-4","volume":"9","author":"K Zerres","year":"1999","unstructured":"Zerres K, Davies KE : Workshop report. 59th ENMC International Workshop: Spinal muscular atrophies: recent progress and revised diagnostic criteria. Neuromusc Disord 1999; 9: 272\u2013278.","journal-title":"Neuromusc Disord"},{"key":"BF5201885_CR6","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/ng0797-265","volume":"16","author":"S Lefebvre","year":"1997","unstructured":"Lefebvre S, Burlet P, Liu Q et al: Correlation between severity and SMN protein level in spinal muscular atrophy. Nat Genet 1997; 16: 265\u2013269.","journal-title":"Nat Genet"},{"key":"BF5201885_CR7","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1086\/338627","volume":"70","author":"M Feldk\u00f6tter","year":"2002","unstructured":"Feldk\u00f6tter M, Schwarzer V, Wirth R, Wienker TF, Wirth B : Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet 2002; 70: 358\u2013368.","journal-title":"Am J Hum Genet"},{"key":"BF5201885_CR8","doi-asserted-by":"publisher","first-page":"9808","DOI":"10.1073\/pnas.171105098","volume":"98","author":"JG Chang","year":"2001","unstructured":"Chang JG, Hsieh-Li HM, Jong YJ, Wang NM, Tsai CH, Li H : Treatment of spinal muscular atrophy by sodium butyrate. Proc Natl Acad Sci USA 2001; 98: 9808\u20139813.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF5201885_CR9","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1093\/hmg\/10.24.2841","volume":"10","author":"C Andreassi","year":"2001","unstructured":"Andreassi C, Jarecki J, Zhou J et al: Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients. Hum Mol Genet 2001; 10: 2841\u20132849.","journal-title":"Hum Mol Genet"},{"key":"BF5201885_CR10","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1093\/hmg\/ddg256","volume":"12","author":"L Brichta","year":"2003","unstructured":"Brichta L, Hofmann Y, Hahnen E et al: Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy. Hum Mol Genet 2003; 12: 2481\u20132489.","journal-title":"Hum Mol Genet"},{"key":"BF5201885_CR11","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/ana.10743","volume":"54","author":"CJ Sumner","year":"2003","unstructured":"Sumner CJ, Huynh TN, Markowitz JA et al: Valproic acid increases SMN levels in spinal muscular atrophy patient cells. Ann Neurol 2003; 54: 647\u2013654.","journal-title":"Ann Neurol"},{"key":"BF5201885_CR12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/sj.ejhg.5201102","volume":"12","author":"C Andreassi","year":"2004","unstructured":"Andreassi C, Angelozzi C, Tiziano FD et al: Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy. Eur J Hum Genet 2004; 12: 59\u201365.","journal-title":"Eur J Hum Genet"},{"key":"BF5201885_CR13","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/ana.20548","volume":"58","author":"SM Grzeschik","year":"2005","unstructured":"Grzeschik SM, Ganta M, Prior TW, Heavlin WD, Wang CH : Hydroxyurea enhances SMN2 gene expression in spinal muscular atrophy cells. Ann Neurol 2005; 58: 194\u2013202.","journal-title":"Ann Neurol"},{"key":"BF5201885_CR14","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1093\/hmg\/ddi205","volume":"14","author":"J Jarecki","year":"2005","unstructured":"Jarecki J, Chen X, Bernardino A et al: Diverse small-molecule modulators of SMN expression found by high-throughput compound screening: early leads towards a therapeutic for spinal muscular atrophy. Hum Mol Genet 2005; 14: 2003\u20132018.","journal-title":"Hum Mol Genet"},{"key":"BF5201885_CR15","doi-asserted-by":"publisher","first-page":"4114","DOI":"10.1073\/pnas.0633863100","volume":"100","author":"LA Skordis","year":"2003","unstructured":"Skordis LA, Dunckley MG, Yue B, Eperon IC, Muntoni F : Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts. Proc Natl Acad Sci USA 2003; 100: 4114\u20134119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF5201885_CR16","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.ymthe.2005.08.022","volume":"12","author":"C Madocsai","year":"2005","unstructured":"Madocsai C, Lim SR, Geib T, Lam BJ, Hertel KJ : Correction of SMN2 pre-mRNA splicing by antisense U7 small nuclear RNAs. Mol Ther 2005; 12: 1013\u20131022.","journal-title":"Mol Ther"},{"key":"BF5201885_CR17","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ymthe.2006.01.012","volume":"14","author":"T Baughan","year":"2006","unstructured":"Baughan T, Shababi M, Coady TH, Dickson HM, Tullis GE, Lorson CL : Stimulating full-length SMN2 expression by delivering bifunctional RNAs via a viral vector. Mol Ther 2006; 14: 54\u201362.","journal-title":"Mol Ther"},{"key":"BF5201885_CR18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.nurx.2006.01.010","volume":"3","author":"CJ Sumner","year":"2006","unstructured":"Sumner CJ : Therapeutics development for spinal muscular atrophy. NeuroRx 2006; 3: 235\u2013245.","journal-title":"NeuroRx"},{"key":"BF5201885_CR19","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1136\/jmg.38.4.240","volume":"38","author":"P Saugier-Veber","year":"2001","unstructured":"Saugier-Veber P, Drouot N, Lefebvre S et al: Detection of heterozygous SMN1 deletions in SMA families using a simple fluorescent multiplex PCR method. J Med Genet 2001; 38: 240\u2013243.","journal-title":"J Med Genet"},{"key":"BF5201885_CR20","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/sj.ejhg.5201661","volume":"14","author":"P Saugier-Veber","year":"2006","unstructured":"Saugier-Veber P, Goldenberg A, Drouin-Garraud V et al: Simple detection of genomic microdeletions and microduplications using QMPSF in patients with idiopathic mental retardation. Eur J Hum Genet 2006; 14: 1009\u20131017.","journal-title":"Eur J Hum Genet"},{"key":"BF5201885_CR21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0022-510X(99)00325-1","volume":"173","author":"YJ Jong","year":"2000","unstructured":"Jong YJ, Chang JG, Lin SP et al: Analysis of the mRNA transcripts of the survival motor neuron (SMN) gene in the tissue of an SMA fetus and the peripheral blood mononuclear cells of normals, carriers and SMA patients. J Neurol Sci 2000; 173: 147\u2013153.","journal-title":"J Neurol Sci"},{"key":"BF5201885_CR22","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1086\/302372","volume":"64","author":"A Echaniz-Laguna","year":"1999","unstructured":"Echaniz-Laguna A, Miniou P, Bartholdi D, Melki J : The promoters of the survival motor neuron gene (SMN) and its copy (SMNc) share common regulatory elements. Am J Hum Genet 1999; 64: 1365\u20131370.","journal-title":"Am J Hum Genet"},{"key":"BF5201885_CR23","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/S0167-4781(99)00060-3","volume":"1445","author":"UR Monani","year":"1999","unstructured":"Monani UR, McPherson JD, Burghes AH : Promoter analysis of the human centromeric and telomeric survival motor neuron genes (SMNC and SMNT). Biochim Biophys Acta 1999; 1445: 330\u2013336.","journal-title":"Biochim Biophys Acta"},{"key":"BF5201885_CR24","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/sj.ejhg.5201217","volume":"12","author":"B Boda","year":"2004","unstructured":"Boda B, Mas C, Giudicelli C et al: Survival motor neuron SMN1 and SMN2 gene promoters: identical sequences and differential expression in neurons and non-neuronal cells. Eur J Hum Genet 2004; 12: 729\u2013737.","journal-title":"Eur J Hum Genet"},{"key":"BF5201885_CR25","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1126\/science.1074962","volume":"298","author":"L Pellizzoni","year":"2002","unstructured":"Pellizzoni L, Yong J, Dreyfuss G : Essential role for the SMN complex in the specificity of snRNP assembly. Science 2002; 298: 1775\u20131779.","journal-title":"Science"},{"key":"BF5201885_CR26","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1002\/ana.20836","volume":"59","author":"L Brichta","year":"2006","unstructured":"Brichta L, Holker I, Haug K, Klockgether T, Wirth B : In vivo activation of SMN in spinal muscular atrophy carriers and patients treated with valproate. Ann Neurol 2006; 59: 970\u2013975.","journal-title":"Ann Neurol"},{"key":"BF5201885_CR27","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/sj.ejhg.5201320","volume":"13","author":"C Brahe","year":"2005","unstructured":"Brahe C, Vitali T, Tiziano FD et al: Phenylbutyrate increases SMN gene expression in spinal muscular atrophy patients. Eur J Hum Genet 2005; 13: 256\u2013259.","journal-title":"Eur J Hum Genet"},{"key":"BF5201885_CR28","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1212\/01.wnl.0000201929.56928.13","volume":"66","author":"CJ Sumner","year":"2006","unstructured":"Sumner CJ, Kolb SJ, Harmison GG et al: SMN mRNA and protein levels in peripheral blood: biomarkers for SMA clinical trials. Neurology 2006; 66: 1067\u20131073.","journal-title":"Neurology"},{"key":"BF5201885_CR29","doi-asserted-by":"publisher","first-page":"13312","DOI":"10.1073\/pnas.230364197","volume":"97","author":"DA Kerr","year":"2000","unstructured":"Kerr DA, Nery JP, Traystman RJ, Chau BN, Hardwick JM : Survival motor neuron protein modulates neuron-specific apoptosis. Proc Natl Acad Sci USA 2000; 97: 13312\u201313317.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF5201885_CR30","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/hmg\/ddi078","volume":"14","author":"TT Le","year":"2005","unstructured":"Le TT, Pham LT, Butchbach ME et al: SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN. Hum Mol Genet 2005; 14: 845\u2013857.","journal-title":"Hum Mol Genet"},{"key":"BF5201885_CR31","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1006\/bbrc.1995.2135","volume":"213","author":"M Gennarelli","year":"1995","unstructured":"Gennarelli M, Lucarelli M, Capon F et al: Survival motor neuron gene transcript analysis in muscles from spinal muscular atrophy patients. Biochem Biophys Res Commun 1995; 213: 342\u2013348.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF5201885_CR32","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1093\/hmg\/7.12.1927","volume":"7","author":"P Burlet","year":"1998","unstructured":"Burlet P, Huber C, Bertrandy S et al: The distribution of SMN protein complex in human fetal tissues and its alteration in spinal muscular atrophy. Hum Mol Genet 1998; 7: 1927\u20131933.","journal-title":"Hum Mol Genet"},{"key":"BF5201885_CR33","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0022-510X(99)00325-1","volume":"173","author":"YJ Jong","year":"2000","unstructured":"Jong YJ, Chang JG, Lin SP et al: Analysis of the mRNA transcripts of the survival motor neuron (SMN) gene in the tissue of an SMA fetus and the peripheral blood mononuclear cells of normals, carriers and SMA patients. J Neurol Sci 2000; 173: 147\u2013153.","journal-title":"J Neurol Sci"},{"key":"BF5201885_CR34","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/jnen\/64.3.215","volume":"64","author":"C Soler-Botija","year":"2005","unstructured":"Soler-Botija C, Cusco I, Caselles L, Lopez E, Baiget M, Tizzano EF : Implication of fetal SMN2 expression in type I SMA pathogenesis: protection or pathological gain of function? J Neuropathol Exp Neurol 2005; 64: 215\u2013223.","journal-title":"J Neuropathol Exp Neurol"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/5201885.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/5201885","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/5201885.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T01:39:10Z","timestamp":1684373950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/5201885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,4]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["BF5201885"],"URL":"https:\/\/doi.org\/10.1038\/sj.ejhg.5201885","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,4]]}}}